InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: antihama post# 2456

Thursday, 01/17/2019 1:57:58 PM

Thursday, January 17, 2019 1:57:58 PM

Post# of 3283
JT and TR have not waivered in their enthusiasm around Rolontis. I also note the recent additions to the BOD are Neulasta Rolontis people.

I think Qapzola could be a $100-200M or higher drug and JT can't even remember its name. That said he is excited about Rolontis.

Anything less than $300M would likely be a failure in JT's eyes.

For whatever reason these guys insist they know how to take market.

Should be fun to watch, especially since I don't think the market is giving it any value even as we approach getting a PDUFA.